login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
LAKESHORE BIOPHARMA CO LTD (LSB) Stock News
USA
- NASDAQ:LSB -
KYG9845F2080
-
Common Stock
0.627
USD
-0.16 (-20.68%)
Last: 9/19/2025, 8:26:53 PM
0.5399
USD
-0.09 (-13.89%)
After Hours:
9/19/2025, 8:26:53 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
LSB Latest News, Press Relases and Analysis
All
Press Releases
a month ago - By: LakeShore Biopharma Co., Ltd.
LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting
a month ago - By: Benzinga
- Mentions:
GRI
IVA
COCP
ADXN
...
12 Health Care Stocks Moving In Friday's Pre-Market Session
a month ago - By: LakeShore Biopharma Co., Ltd.
LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq
a month ago - By: LakeShore Biopharma Co., Ltd.
LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
2 months ago - By: Stocktwits
LakeShore Biopharma Receives Revised Proposal To Acquire Company
2 months ago - By: Benzinga
- Mentions:
CVM
TLX
COO
GLMD
...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
2 months ago - By: LakeShore Biopharma Co., Ltd.
LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee
2 months ago - By: Stocktwits
LakeShore Biopharma Just Got An Acquisition Proposal From Oceanpine Capital: More Details Inside
3 months ago - By: LakeShore Biopharma Co., Ltd.
LakeShore Biopharma Announces Fiscal Year 2025 Financial Results
4 months ago - By: LakeShore Biopharma Co., Ltd.
LakeShore Biopharma Announces US$15 Million Private Placement Financing
a year ago - By: LakeShore Biopharma Co., Ltd
Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024
a year ago - By: LakeShore Biopharma Co., Ltd.
LakeShore Biopharma Announces Leadership Transitions
6 months ago - By: LakeShore Biopharma Co., Ltd.
LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA™ Rabies Vaccine (Vero Cell)
10 months ago - By: LakeShore Biopharma
LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance
10 months ago - By: LakeShore Biopharma Co., Ltd
LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China
10 months ago - By: LakeShore Biopharma Co., Ltd
LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China
a year ago - By: LakeShore Biopharma Co., Ltd
- Mentions:
YS
LakeShore Biopharma Initiates Biologics License Application of PIKA Rabies Vaccine to the Drug Regulatory Authority of Pakistan
a year ago - By: LakeShore Biopharma Co., Ltd
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
a year ago - By: LakeShore Biopharma Co., Ltd.
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine
a year ago - By: LakeShore Biopharma Co., Ltd.
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance
a year ago - By: LakeShore Biopharma Co., Ltd.
LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation
a year ago - By: LakeShore Biopharma Co., Ltd
LakeShore Biopharma Announces Financial Results for Fiscal Year 2024
a year ago - By: LakeShore Biopharma Co., Ltd
LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition
Please enable JavaScript to continue using this application.